It has FDA-approved labeling for use in the treatment of acute symptomatic deep-vein thrombosis (DVT) with or without pulmonary embolism (PE) when administered in conjunction with warfarin sodium.

A double-blind, randomized, placebo- controlled crossover study evaluated single-dose warfarin sodium (25 mg) given in the presence of multiple- dose moxifloxacin administration (400 mg/day for ...

and Warfarin sodium tablets. Both companies have agreed to cooperate in the ongoing multistate litigations and to a series of internal reforms to ensure fair competition and compliance with ...